Global Ganja Report

Moroccan lawmakers on Dec. 4 opened an unprecedented debate on legalizing medical and industrial uses of cannabis. The discussion of positive uses of cannabis cultivation "in creating an alternative economy" in Morocco, one of the world's top exporters, was convened following a campaign by dissident politicians.  "We are organizing a research day in parliament...on the use of medical kif, with Moroccan and international experts present," said Mehdi Bensaid, an MP with the Party of Authenticity and Modernity (PAM), adding that lawmakers are "looking at controlled rather than total legalization." Activists from Switzerland spoke about their country's experience with a recent decrim law at the session, which Bensaid called "the first step towards a draft law."

British firm GW Pharmaceuticals has won "orphan drug status"—a special category for agents developed to treat rare diseases—from the US Food and Drug Administration (FDA) for Epidiolex, a derivative of cannabidiol (CBD), to treat Dravet syndrome, a severe form epilepsy. In Utah, parents who are lobbying to import CBD-rich cannabis strains from Colorado, say they will keep up their campaign. "This changes nothing" in regard to children being able to access CBD, said Jennifer May, mother of 11-year-old Stockton, who suffers from Dravet syndrome. "On the other hand, it does lend credibility to the potential of CBD as a treatment." Like many Dravet patients, Stockton has tried dozens of pharmaceutical fixes, and run out of options. He can no longer use the toilet and has to be fed from a tube. "Orphan drug" designation qualifies GW for tax credits and exclusive rights to the drug if approved. But FDA approval for Epidiolex could take a year or more. (Salt Lake Tribune, Nov. 18)

Israel has the world's highest proportion of registered medical marijuana users—but the program has been kept under tight control of the Health Ministry. Now, Israel's parliament, the Knesset, is set to vote on a bill that would allow private physicians to prescribe cannabis for their patients. Health Minister Yael German opposes the measure, making the usual argument that it would open the floodgates of recreational use: "It would not be unrealistic to assume that there would be patients who would pressure doctors to write them a cannabis prescription for any bump, headache or toothache."

The US Supreme Court on Oct. 7 rejected a challenge to the federal government's classification of cannabis as a Schedule I drug with no legitimate medical use. Challenger Americans for Safe Access contended that more than 200 studies have established that cannabis is safe and effective in relieving pain and nausea, and in relieving the effects of chemotherapy, among other medical uses. But federal courts have let stand the Drug Enforcement Administration's stance that the studies are insufficient.

Medical marijuana advocates Americans for Safe Access (ASA) will join the Brownie Mary Democratic Club of Riverside County to stage a peaceful counter-demonstration at 11 AM on Monday, Sept. 23, against the 2013 National Marijuana Policy & Strategy Conference being held in Rancho Cucamonga. The conference is sponsored by some of the same groups that have strenuously lobbied against statewide regulations in California, including the California Narcotic Officers' Association and the California Peace Officers' Association.

Deputy Attorney General James Cole, the same who authored a notorious 2011 memo asserting that federal cannabis enforcement remains a "core priority" even in states that have passed medical marijuana laws, has just issued a new memorandum seeming to clarify Justice Department reaction to the legalization measures in Colorado and Washington state. While it is written in the usual dense bureaucratese that often hides as much as it reveals, on balance it appears to represent a retreat from the hardline posture the Obama administration has assumed regarding medicinal cannabis over the past two years. The text of the Aug. 29 memo is provided by our comrades at CelebStoner:

US Attorney General Eric Holder delivered a speech Aug. 12 to the annual meeting of the American Bar Association in which he outlined a new sentencing and enforcement strategy. Holder said that the Department of Justice is "considering compassionate release for inmates facing extraordinary or compelling circumstances." Holder also spoke out against the indiscriminate use of mandatory minimum sentencing for non-violent offenders. There are currently more than two dozen federal medical marijuana patients and providers who are serving sentences for violating federal marijuana laws, despite being in compliance with the laws of their respective states.

Gov. Pat Quinn signed HB1 into law Aug. 1, making Illinois the 20th state to legalize medical marijuana. Nearly 40% of people in the US now live in states that have adopted such laws. The Illinois Compassionate Use of Medical Cannabis Pilot Program Act creates a framework to protect physicians and certain qualified medical marijuana patients from arrest and prosecution. HB1 was passed 35-21 by the Illinois House in April, and 61-57 by the Senate in May. HB1, which is scheduled to sunset in four years, was called one of the most restrictive laws in the country by its Senate sponsor Bill Haine (D-Alton). The new law is set to take effect on January 1, 2014.